Dual mechanism of human ATG10S in suppressing MEF2A-Driven pro-inflammatory responses
Miao-Qing Zhang, Zheng-Hao Wang, Jing-Pu Zhang · 2026
Read Dual mechanism of human ATG10S in suppressing MEF2A-Driven pro-inflammatory responses by Miao-Qing Zhang, Zheng-Hao Wang, Jing-Pu Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618858.txt.
Description
Miao-Qing Zhang and colleagues report a 2026 study of a newly described form of the autophagy protein ATG10, called ATG10S, as a possible brake on cytokine storms. Cytokine storms, the runaway release of inflammatory signals, worsen many illnesses, yet drugs aimed at single cytokines often fall short because the cascade is broad. The team tested ATG10S in zebrafish and human cell models inflamed with viral spike protein or bacterial lipopolysaccharide.
ATG10S lowered a set of inflammatory cytokines all controlled by the transcription factor MEF2A, and it did so by two routes at once. It bound MEF2A directly and sent it for selective destruction through the cell's recycling system, while also blocking a rival signaling partner from binding MEF2A. That dual action cut both MEF2A levels and activity, restored recycling flow that inflammation had impaired, and spared unrelated transcription factors.
Catalog record
| CREATOR | Miao-Qing Zhang, Zheng-Hao Wang, Jing-Pu Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |